Trials / Conditions / Stage III Primary Peritoneal Cancer AJCC v7

Stage III Primary Peritoneal Cancer AJCC v7

12 registered clinical trials studyying Stage III Primary Peritoneal Cancer AJCC v7.

Status	Trial	Sponsor	Phase
Completed	Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, NCT02713386	NRG Oncology	Phase 1 / Phase 2
Withdrawn	Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With NCT03902379	Rutgers, The State University of New Jersey	N/A
Active Not Recruiting	Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontl NCT02726997	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, NCT02520154	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P NCT02659241	M.D. Anderson Cancer Center	EARLY_Phase 1
Completed	Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tu NCT02316834	M.D. Anderson Cancer Center	EARLY_Phase 1
Completed	Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopia NCT02042430	National Cancer Institute (NCI)	EARLY_Phase 1
Active Not Recruiting	Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi NCT01970722	City of Hope Medical Center	Phase 1
Completed	Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian NCT01504126	M.D. Anderson Cancer Center	EARLY_Phase 1
Unknown	Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovar NCT01366183	Gynecologic Oncology Group	—
Unknown	Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, NCT01372787	Gynecologic Oncology Group	—
Completed	Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi NCT00951496	National Cancer Institute (NCI)	Phase 3